Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glycemic Impact on Glioblastoma Outcomes

NCT03235934 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03235934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03235934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glycemic Impact on Glioblastoma Outcomes
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Withdrawn
Start date
December 1, 2018
Completion date
January 24, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme, hyperglycemia